StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
10
Publishing Date
2021 - 05 - 21
9
2021 - 05 - 20
1
Sector
Health services
3
Health technology
8
Tags
Acquisition
4
Acquisition corp
2
Actinic keratosis
3
Application
2
Approval
10
Artificial intelligence
2
Awards
8
Bioscience
4
Biotech
2
Biotech-bay
2
Biotechnology
2
Brands
3
Breast cancer
2
Cancer
10
Chmp
11
Clinical-trials-phase-iii
2
Collaboration
2
Commercialization
2
Conference
27
Covid
13
Covid-19
6
Device
3
Diagnostic
4
Diagnostics
3
Disease
6
Distribution
2
Ema
4
Energy
5
Europe
8
Ev
8
Events
13
Fda
5
Fda approval
4
Financial results
6
Grant
5
Granted
5
Growing
3
Growth
10
Health
4
Hotel
4
Injection
4
Iot
6
Lung cancer
4
N/a
233
Offering
5
Phase 3
3
Positive
15
Presentation
14
Research
11
Results
15
Technology
5
Test
3
Therapeutics
4
Therapy
5
Tirbanibulin
3
Travel
5
Treatment
15
Trial
6
Vaccine
9
Women
3
Entities
Abbvie inc.
1
Adc therapeutics sa
1
Agios pharmaceuticals, inc.
1
Alnylam pharmaceuticals, inc.
1
Amgen inc.
1
Aveo pharmaceuticals, inc.
1
Beigene, ltd.
2
Blueprint medicines corporation
1
Bristol-myers squibb company
1
Clovis oncology, inc.
1
Eli lilly and company
1
Epizyme, inc.
1
Exelixis, inc.
1
Genmab a/s
1
Guardant health, inc.
3
Illumina, inc.
1
Incyte corporation
1
Johnson & johnson
3
Karyopharm therapeutics inc.
1
Lantheus holdings, inc.
1
Myriad genetics, inc.
2
Pfizer, inc.
1
Regeneron pharmaceuticals, inc.
1
Rigel pharmaceuticals, inc.
1
Sanofi
1
Verastem, inc.
1
Y-mabs therapeutics, inc.
1
Symbols
ABBV
1
ADCT
1
AGIO
1
ALNY
1
AMGN
1
AVEO
1
BGNE
2
BMY
1
BPMC
1
CLVS
1
EPZM
1
EXEL
1
GH
3
GMAB
1
ILMN
1
INCY
1
JNJ
3
KPTI
1
LLY
1
LNTH
1
MYGN
2
PFE
1
REGN
1
RIGL
1
SNY
1
VSTM
1
YMAB
1
Exchanges
Nasdaq
8
Nyse
4
Crawled Date
2024 - 04 - 09
16
2024 - 04 - 08
15
2024 - 03 - 06
13
2024 - 03 - 05
23
2023 - 12 - 06
12
2023 - 11 - 28
11
2023 - 11 - 06
11
2023 - 11 - 03
19
2023 - 10 - 31
11
2023 - 10 - 23
19
2023 - 10 - 04
16
2023 - 10 - 03
13
2023 - 09 - 27
17
2023 - 09 - 11
12
2023 - 05 - 25
14
2023 - 04 - 19
12
2023 - 04 - 18
17
2023 - 04 - 17
17
2023 - 03 - 15
17
2023 - 03 - 14
25
2022 - 12 - 08
17
2022 - 12 - 01
11
2022 - 11 - 10
18
2022 - 10 - 12
11
2022 - 10 - 06
12
2022 - 10 - 05
18
2022 - 09 - 12
13
2022 - 06 - 06
11
2022 - 04 - 08
27
2022 - 03 - 09
13
2022 - 03 - 08
32
2022 - 03 - 07
12
2022 - 01 - 19
14
2022 - 01 - 18
11
2021 - 12 - 10
19
2021 - 12 - 09
13
2021 - 11 - 30
12
2021 - 11 - 12
16
2021 - 11 - 09
12
2021 - 10 - 28
11
2021 - 10 - 25
11
2021 - 10 - 13
10
2021 - 10 - 07
19
2021 - 10 - 04
10
2021 - 10 - 01
30
2021 - 09 - 30
11
2021 - 09 - 20
13
2021 - 09 - 14
10
2021 - 06 - 04
12
2021 - 06 - 03
11
2021 - 05 - 21
10
2021 - 05 - 20
13
2021 - 04 - 12
16
2021 - 04 - 10
15
2021 - 04 - 09
15
2021 - 04 - 08
10
2021 - 03 - 21
11
2021 - 03 - 10
16
2020 - 12 - 09
13
2020 - 12 - 01
20
Crawled Time
00:00
1
12:00
1
16:00
1
17:00
1
18:33
2
19:00
1
20:00
1
22:00
1
23:00
1
Source
www.biospace.com
3
www.fda.gov
2
www.globenewswire.com
1
www.myriad.com
1
www.prnewswire.com
3
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Cancer
crawled date :
2021 - 05 - 21
save search
Guardant360® CDx Receives FDA Approval as Companion Diagnostic for Janssen’s RYBREVANT™ (amivantamab-vmjw) for Use in Patients with Advanced Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations
Published:
2021-05-21
(Crawled : 23:00)
- biospace.com/
GH
M
|
$16.08
-3.54%
-3.67%
1.9M
|
Health Services
|
-86.58%
|
O:
0.53%
H:
2.94%
C:
0.73%
fda
lung cancer
fda approval
cancer
approval
diagnostic
Insights on the Breast Cancer Liquid Biopsy Global Market to 2027 - Opportunity Analysis and Industry Forecasts
Published:
2021-05-21
(Crawled : 22:00)
- prnewswire.com
GH
M
|
$16.08
-3.54%
-3.67%
1.9M
|
Health Services
|
Email alert
Add to watchlist
MYGN
F
|
$18.515
0.03%
0.03%
490K
|
Health Technology
|
Email alert
Add to watchlist
cancer
breast cancer
Genmab Announces that Janssen has been Granted U.S. FDA Approval for RYBREVANT™ (amivantamab-vmjw) for Patients with Metastatic Non-small Cell Lung Cancer with Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion Mutations
Published:
2021-05-21
(Crawled : 20:00)
- globenewswire.com
GMAB
|
$28.72
1.38%
1.36%
360K
|
Health Technology
|
Email alert
Add to watchlist
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
Email alert
Add to watchlist
fda
lung cancer
fda approval
cancer
ev
growth
approval
RYBREVANT™ (amivantamab-vmjw) Receives FDA Approval as the First Targeted Treatment for Patients with Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations
Published:
2021-05-21
(Crawled : 19:00)
- prnewswire.com
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
Email alert
Add to watchlist
treatment
fda
lung cancer
fda approval
cancer
approval
Hematology/Oncology (Cancer) Approvals & Safety Notifications
Published:
2021-05-21
(Crawled : 18:33)
- fda.gov
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-35.19%
|
O:
0.22%
H:
0.97%
C:
-0.65%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
264.01%
|
O:
0.24%
H:
0.96%
C:
-0.06%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-26.97%
|
O:
0.36%
H:
1.01%
C:
-0.28%
ADCT
|
$4.72
-0.84%
0.0%
320K
|
Health Technology
|
-76.95%
|
O:
2.54%
H:
0.48%
C:
-0.29%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
42.1%
|
O:
0.35%
H:
0.65%
C:
-1.19%
YMAB
|
$15.15
1.0%
0.99%
470K
|
Health Technology
|
-58.02%
|
O:
0.58%
H:
1.24%
C:
-1.66%
VSTM
|
$9.86
-3.62%
-3.75%
150K
|
Health Technology
|
208.46%
|
O:
0.63%
H:
2.49%
C:
-0.62%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-14.32%
|
O:
-0.43%
H:
0.2%
C:
0.02%
RIGL
|
$1.07
1.91%
1.87%
810K
|
Health Technology
|
-70.65%
|
O:
0.82%
H:
1.08%
C:
-1.62%
REGN
|
$896.27
0.26%
0.25%
500K
|
Health Technology
|
74.75%
|
O:
0.18%
H:
0.46%
C:
-1.44%
KPTI
|
$1.16
-9.38%
-10.34%
1.4M
|
Health Technology
|
-87.72%
|
O:
0.31%
H:
1.15%
C:
-1.46%
INCY
|
$52.3
-0.98%
-0.99%
2.2M
|
Health Technology
|
-37.31%
|
O:
0.57%
H:
0.6%
C:
-1.46%
ILMN
|
$117.43
0.63%
0.63%
1.4M
|
Health Technology
|
-70.38%
|
O:
0.33%
H:
2.2%
C:
0.21%
EXEL
|
$22.51
0.09%
0.09%
2.3M
|
Health Technology
|
-7.44%
|
O:
0.08%
H:
1.64%
C:
0.45%
EPZM
|
$1.47
-1.34%
0.0%
|
Health Technology
|
-83.08%
|
O:
1.04%
H:
0.0%
C:
-2.62%
CLVS
|
$0.0812
-3.94%
|
Health Technology
|
-98.37%
|
O:
0.95%
H:
1.31%
C:
-2.81%
BPMC
|
$86.87
-2.28%
-2.34%
800K
|
Health Technology
|
-8.99%
|
O:
1.12%
H:
0.84%
C:
-0.08%
BGNE
|
$129.51
-1.86%
-1.89%
300K
|
Health Technology
|
-62.37%
|
O:
0.1%
H:
1.6%
C:
0.88%
AVEO
|
$15.0
0.0%
0
|
Health Technology
|
115.45%
|
O:
1.19%
H:
1.71%
C:
-0.33%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
6.75%
|
O:
0.71%
H:
0.14%
C:
-1.06%
ALNY
|
$144.315
-0.58%
-0.59%
700K
|
Health Technology
|
3.08%
|
O:
0.38%
H:
1.01%
C:
-0.41%
AGIO
|
$29.52
0.31%
0.3%
750K
|
Health Technology
|
-47.97%
|
O:
0.86%
H:
1.27%
C:
-0.24%
cancer
approval
FDA grants accelerated approval to amivantamab-vmjw for metastatic non-small cell lung cancer
Published:
2021-05-21
(Crawled : 18:33)
- fda.gov
GH
M
|
$16.08
-3.54%
-3.67%
1.9M
|
Health Services
|
Email alert
Add to watchlist
fda
cancer
approval
granted
grant
FDA Approves First Targeted Therapy for Subset of Non-Small Cell Lung Cancer
Published:
2021-05-21
(Crawled : 17:00)
- prnewswire.com
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-13.54%
|
O:
0.15%
H:
0.82%
C:
-0.22%
fda
lung cancer
therapy
cancer
approval
fda approval
Lantheus Holdings Announces Presentation Featuring 18F-DCFPyL PET/CT, its PSMA-Targeted Prostate Cancer Imaging Agent at the 2021 ASCO Annual Meeting
Published:
2021-05-21
(Crawled : 16:00)
- biospace.com/
LNTH
|
$63.8
2.36%
2.3%
800K
|
Health Technology
|
200.0%
|
O:
0.94%
H:
2.05%
C:
0.28%
presentation
prostate cancer
cancer
imaging
BeiGene Announces Positive Topline Results from Phase 3 Trial of Tislelizumab in Combination with Chemotherapy as First-Line Treatment for Recurrent or Metastatic Nasopharyngeal Cancer
Published:
2021-05-21
(Crawled : 12:00)
- biospace.com/
BGNE
|
$129.51
-1.86%
-1.89%
300K
|
Health Technology
|
-62.37%
|
O:
0.1%
H:
1.6%
C:
0.88%
treatment
positive
therapy
results
cancer
topline
phase 3
trial
ASCO 2021 Preview: Making Breast Cancer Risk Assessment More Inclusive
Published:
2021-05-20
(Crawled : 00:00)
- myriad.com
MYGN
F
|
$18.515
0.03%
0.03%
490K
|
Health Technology
|
-32.36%
|
O:
1.54%
H:
0.65%
C:
-0.86%
risk
cancer
breast cancer
Gainers vs Losers
67%
33%
Top 10 Gainers
AGBA
|
News
|
$1.26
215.0%
68.25%
130M
|
Finance
EGOX
|
$0.0515
43.06%
30.1%
330M
|
OLB
4
|
$0.33
-14.95%
25.53%
840K
|
Technology Services
NVFY
|
$2.77
31.28%
23.83%
33M
|
Consumer Durables
ZCMD
|
$1.87
28.97%
22.46%
31M
|
Commercial Services
RCON
|
$0.1112
13.01%
21.28%
1.7M
|
Distribution Services
INSG
|
$3.03
25.21%
20.13%
330K
|
Electronic Technology
GCTK
|
$0.8191
22.25%
18.2%
190K
|
Manufacturing
WLGS
|
$0.59
18.0%
17.9%
2.3M
|
ASNS
|
$0.828
21.75%
17.86%
18K
|
Your saved searches
Save your searches and get alerts when important news are released.